BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Anticancer prodrugs, Tamoxifen, rs2300478, NEUROG3, T cell differentiation, Leukocyte)
Bookmark Forward

QuickView for nsaids (compound)


Genetic Markers

Most Correlated Genes

  1. LCN2
  2. CXCL1
  3. ATF3
  4. PTGS2
  5. FOS
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. PILON_KLF1_TARGETS_DN
  2. heterocyclic compound binding
  3. organic cyclic compound binding
  4. regulation of nitrogen compound metabolic process
  5. cytosol
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Leukemia cell lines treated with DMSO or tanshinone IIA
  2. Abdominal skin of mice exposed to shikonin (RNA expression)
  3. Expression profile of shikonin resistant K562 myeloid leukemia cell line
  4. Peripheral blood cells of rheumatoid arthritis patients receiving anti-TNFa therapy
  5. Proteogenomics of synaptosomal mitochondrial oxidative stress
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).
  2. Extracellular vesicle miRNAs drive aberrant macrophage responses in NSAID-exacerbated respiratory di…
  3. Risk factors of NSAID-exacerbated respiratory disease: A population-based study.
  4. Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
  5. Evaluation and Updated Classification of Acute Hypersensitivity Reactions to Nonsteroidal Anti-Infla…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Retrospective Review of NSAIDS in the Postpartum Period
  2. NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management
  3. NSAIDS vs Opioids in Tibial Fractures
  4. PGE2 Levels in Patient Treated With NSAIDs
  5. Postpartum NSAIDS and Maternal Hypertension
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.